Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Rey

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimenFrançois Raffi, Matthieu Hanf, Tristan Ferry, et al.
The Journal of Antimicrobial Chemotherapy|November 10, 2017
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimenFrançois Raffi, Matthieu Hanf, Tristan Ferry, et al.
Plos One|March 25, 2022
Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in FranceTeresa Rojas Rojas, Isabelle Poizot-Martin, David Rey, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 2, 2024
Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study-ANRS0001s COV-POPARTPaul Loubet, Jean-Daniel Lelievre, Alexis François, et al.
Ebiomedicine|August 5, 2020
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern FranceSamira Fafi-Kremer, Timothée Bruel, Yoann Madec, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2019
Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat'AIDS Cohort StudyMarie Demontès, Sabrina Eymard Duvernay, Clotilde Allavena, et al.
Ebiomedicine|August 29, 2021
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfectionFloriane Gallais, Pierre Gantner, Timothée Bruel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2020
Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C VirusBoun Kim Tan, Mathieu Chalouni, Dominique Salmon Ceron, et al.
Pharmaceutics|April 3, 2021
Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 InfectionAna Castro-Balado, Cristina Mondelo-García, Letricia Barbosa-Pereira, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
The Journal of Antimicrobial Chemotherapy|September 30, 2017
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimenFrançois Raffi, Matthieu Hanf, Tristan Ferry, et al.
The Journal of Antimicrobial Chemotherapy|November 10, 2017
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimenFrançois Raffi, Matthieu Hanf, Tristan Ferry, et al.
Plos One|March 25, 2022
Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in FranceTeresa Rojas Rojas, Isabelle Poizot-Martin, David Rey, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 2, 2024
Humoral response after mRNA COVID-19 primary vaccination and single booster dose in people living with HIV compared to controls: A French nationwide multicenter cohort study-ANRS0001s COV-POPARTPaul Loubet, Jean-Daniel Lelievre, Alexis François, et al.
Ebiomedicine|August 5, 2020
Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern FranceSamira Fafi-Kremer, Timothée Bruel, Yoann Madec, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2019
Multimorbidity in Elderly Persons According to the Year of Diagnosis of Human Immunodeficiency Virus Infection: A Cross-sectional Dat'AIDS Cohort StudyMarie Demontès, Sabrina Eymard Duvernay, Clotilde Allavena, et al.
Ebiomedicine|August 29, 2021
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfectionFloriane Gallais, Pierre Gantner, Timothée Bruel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2020
Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C VirusBoun Kim Tan, Mathieu Chalouni, Dominique Salmon Ceron, et al.
Pharmaceutics|April 3, 2021
Development and Characterization of Inhaled Ethanol as a Novel Pharmacological Strategy Currently Evaluated in a Phase II Clinical Trial for Early-Stage SARS-CoV-2 InfectionAna Castro-Balado, Cristina Mondelo-García, Letricia Barbosa-Pereira, et al.
Pageof 11